UBS Group’s Orchestra BioMed OBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.1K | Buy |
26,139
+8,869
| +51% | +$23.8K | ﹤0.01% | 6237 |
|
|
2025
Q1 | $73.9K | Sell |
17,270
-6,795
| -28% | -$29.1K | ﹤0.01% | 6009 |
|
|
2024
Q4 | $96.3K | Buy |
24,065
+12,583
| +110% | +$50.3K | ﹤0.01% | 5685 |
|
|
2024
Q3 | $59K | Buy |
11,482
+4,328
| +60% | +$22.2K | ﹤0.01% | 5512 |
|
|
2024
Q2 | $58.3K | Sell |
7,154
-7,572
| -51% | -$61.7K | ﹤0.01% | 5432 |
|
|
2024
Q1 | $77.6K | Buy |
14,726
+1,294
| +10% | +$6.82K | ﹤0.01% | 5167 |
|
|
2023
Q4 | $123K | Buy |
13,432
+5,938
| +79% | +$54.2K | ﹤0.01% | 4875 |
|
|
2023
Q3 | $65.3K | Buy |
7,494
+79
| +1% | +$689 | ﹤0.01% | 4995 |
|
|
2023
Q2 | $51.9K | Buy |
+7,415
| New | +$51.9K | ﹤0.01% | 5393 |
|
|
2022
Q4 | – | Sell |
-2,824
| Closed | -$28K | – | 9716 |
|
|
2022
Q3 | $28K | Buy |
2,824
+2,327
| +468% | +$23.1K | ﹤0.01% | 5872 |
|
|
2022
Q2 | $5K | Buy |
497
+440
| +772% | +$4.43K | ﹤0.01% | 7866 |
|
|
2022
Q1 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 8838 |
|
|
2021
Q4 | – | Sell |
-537
| Closed | -$5K | – | 9306 |
|
|
2021
Q3 | $5K | Sell |
537
-590
| -52% | -$5.49K | ﹤0.01% | 7397 |
|
|
2021
Q2 | $12K | Buy |
1,127
+249
| +28% | +$2.65K | ﹤0.01% | 6791 |
|
|
2021
Q1 | $10K | Buy |
878
+851
| +3,152% | +$9.69K | ﹤0.01% | 6905 |
|
|
2020
Q4 | $0 | Buy |
+27
| New | – | ﹤0.01% | 7534 |
|